Functional Outcomes After MRgFUS Subthalamotomy in Parkinson's Disease

A clinical study dataset of 30 Parkinson's disease patients who underwent unilateral Magnetic Resonance-guided Focused Ultrasound subthalamotomy between June 2021 and June 2024. The data includes motor function and quality of life assessments at baseline, 6-month, and 12-month intervals, published on figshare under a CC-BY-4.0 license.

Use Cases

• Analyze changes in motor experiences of daily living based on MDS-UPDRS II scores
• Evaluate quality of life impact based on PDQ-39 and EQ-5D assessments
• Assess motor function improvements based on MDS-UPDRS III scores
• Study medication reduction effects based on Levodopa Equivalent Daily Dose changes
• Profile safety outcomes based on reported adverse events

Strengths

• Data from a longitudinal study with 12-month follow-up
• 30 patient records with detailed clinical assessments
• Includes primary and secondary endpoints with statistical significance reported

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• Data may reflect selection bias inherent to a single-center clinical study

Provenance

Source

figshare admin karger

Collection Method

Clinical trial data collection from patients undergoing MRgFUS subthalamotomy

Time Range

June 2021 to June 2024

Freshness

Last updated 2026-06-01 07:15:32; freshness should be verified